Jiyeon Yun

698 total citations
19 papers, 500 citations indexed

About

Jiyeon Yun is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jiyeon Yun has authored 19 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jiyeon Yun's work include Lung Cancer Treatments and Mutations (6 papers), Epigenetics and DNA Methylation (4 papers) and Cancer-related gene regulation (4 papers). Jiyeon Yun is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Epigenetics and DNA Methylation (4 papers) and Cancer-related gene regulation (4 papers). Jiyeon Yun collaborates with scholars based in South Korea, United Kingdom and United States. Jiyeon Yun's co-authors include Hye Ryun Kim, Min Hee Hong, Mi Ran Yun, Byoung Chul Cho, Seok‐Young Kim, Kyoung‐Ho Pyo, Sae‐Won Han, Seong Gu Heo, Sang‐Hyun Song and Roland E. Knoblauch and has published in prestigious journals such as Nucleic Acids Research, Biomaterials and Cancer Research.

In The Last Decade

Jiyeon Yun

19 papers receiving 494 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiyeon Yun South Korea 11 258 256 228 95 45 19 500
Hidejiro Torigoe Japan 13 242 0.9× 216 0.8× 186 0.8× 108 1.1× 35 0.8× 28 450
Kyunghee Park South Korea 14 175 0.7× 222 0.9× 156 0.7× 161 1.7× 43 1.0× 45 476
Eri Toyoshima Japan 8 220 0.9× 330 1.3× 236 1.0× 73 0.8× 29 0.6× 15 500
Trine Lindsted United States 7 208 0.8× 254 1.0× 158 0.7× 91 1.0× 86 1.9× 10 439
Hoa Q. Trummell United States 13 305 1.2× 360 1.4× 176 0.8× 94 1.0× 82 1.8× 19 620
Surein Arulananda Australia 9 230 0.9× 228 0.9× 205 0.9× 83 0.9× 50 1.1× 28 469
Lucía Regales United States 6 247 1.0× 286 1.1× 306 1.3× 69 0.7× 17 0.4× 10 457
J. Zugazagoitia United States 3 225 0.9× 291 1.1× 375 1.6× 130 1.4× 19 0.4× 6 527
Holly M. Alley United States 9 266 1.0× 212 0.8× 199 0.9× 104 1.1× 37 0.8× 10 508
Shinsuke Hashida Japan 12 382 1.5× 332 1.3× 345 1.5× 225 2.4× 32 0.7× 30 719

Countries citing papers authored by Jiyeon Yun

Since Specialization
Citations

This map shows the geographic impact of Jiyeon Yun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiyeon Yun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiyeon Yun more than expected).

Fields of papers citing papers by Jiyeon Yun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiyeon Yun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiyeon Yun. The network helps show where Jiyeon Yun may publish in the future.

Co-authorship network of co-authors of Jiyeon Yun

This figure shows the co-authorship network connecting the top 25 collaborators of Jiyeon Yun. A scholar is included among the top collaborators of Jiyeon Yun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiyeon Yun. Jiyeon Yun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Lee, Jin Woo, Jin Hur, Yoo‐Wook Kwon, et al.. (2021). KAI1(CD82) is a key molecule to control angiogenesis and switch angiogenic milieu to quiescent state. Journal of Hematology & Oncology. 14(1). 148–148. 33 indexed citations
3.
Yun, Jiyeon, Sangbin Lim, Seok‐Young Kim, et al.. (2021). Abstract 1106: BRAF and EGFR fusion as a novel mechanism of resistance mechanism to Lazertinib, 3rd- generation EGFR-TKI, in EGFR-mutant NSCLC. Cancer Research. 81(13_Supplement). 1106–1106. 1 indexed citations
4.
Yun, Jiyeon, Han Na Kang, Soo-Hwan Lee, et al.. (2020). Abstract 5199: JNJ-61186372, an EGFR-cMet bispecific antibody, in EGFR Exon 20 insertion-driven advanced non-small cell lung cancer (NSCLC). Cancer Research. 80(16_Supplement). 5199–5199. 3 indexed citations
5.
Yun, Jiyeon, Soo‐Hwan Lee, Seok‐Young Kim, et al.. (2020). Antitumor Activity of Amivantamab (JNJ-61186372), an EGFR–MET Bispecific Antibody, in Diverse Models of EGFR Exon 20 Insertion–Driven NSCLC. Cancer Discovery. 10(8). 1194–1209. 195 indexed citations
6.
Lee, Soo-Hwan, Jiyeon Yun, Chae Won Park, et al.. (2020). Abstract 5198: JNJ-61186372, a novel EGFR/c-Met bispecific antibody, exhibits potent antitumor activity in broad-spectrum of acquired resistance to EGFR-TKIs. Cancer Research. 80(16_Supplement). 5198–5198. 1 indexed citations
7.
Yun, Jiyeon, Min Hee Hong, Seok‐Young Kim, et al.. (2019). YH25448, an Irreversible EGFR-TKI with Potent Intracranial Activity in EGFR Mutant Non–Small Cell Lung Cancer. Clinical Cancer Research. 25(8). 2575–2587. 83 indexed citations
8.
Kim, Seok‐Young, Donghwi Kim, Mi Ran Yun, et al.. (2019). Patient-Derived Cells to Guide Targeted Therapy for Advanced Lung Adenocarcinoma. Scientific Reports. 9(1). 19909–19909. 27 indexed citations
9.
Pyo, Kyoung‐Ho, et al.. (2019). Abstract 4081: Efficacy of MERTK inhibitor in combination with pembrolizumab in lung cancer. Cancer Research. 79(13_Supplement). 4081–4081. 1 indexed citations
10.
Kim, Yu Jin, Soo‐Jin Jeong, Chang‐Seob Seo, et al.. (2018). Simultaneous Determination of the Traditional Herbal Formula Ukgansan and the In Vitro Antioxidant Activity of Ferulic Acid as an Active Compound. Molecules. 23(7). 1659–1659. 13 indexed citations
11.
Yun, Jiyeon, Sang‐Hyun Song, Hwang‐Phill Kim, et al.. (2016). Dynamic cohesin‐mediated chromatin architecture controls epithelial–mesenchymal plasticity in cancer. EMBO Reports. 17(9). 1343–1359. 26 indexed citations
12.
Song, Sang-Hyun, Jiyeon Yun, Yongjun Cha, et al.. (2015). Identification of Long-Range Epigenetic Silencing on Chromosome 15q25 and Its Clinical Implication in Gastric Cancer. American Journal Of Pathology. 185(3). 666–678. 5 indexed citations
13.
Song, Sang-Hyun, et al.. (2015). Aberrant Epigenetic Modifications of <i>LPHN2</o> Function as a Potential Cisplatin-Specific Biomarker for Human Gastrointestinal Cancer. Cancer Research and Treatment. 48(2). 676–686. 16 indexed citations
14.
Yun, Jiyeon, Sang‐Hyun Song, Jinah Park, et al.. (2015). Reduced cohesin destabilizes high-level gene amplification by disrupting pre-replication complex bindings in human cancers with chromosomal instability. Nucleic Acids Research. 44(2). 558–572. 19 indexed citations
15.
Yun, Jiyeon & Young‐Gab Yun. (2012). A Prescriptional Study of Ojeoksan on Clinical Application. Herbal Formula Science. 20(2). 153–164. 6 indexed citations
16.
Hur, Jin, Jiyeon Yun, Chang‐Hwan Yoon, et al.. (2012). Highly angiogenic CXCR4+CD31+ monocyte subset derived from 3D culture of human peripheral blood. Biomaterials. 34(8). 1929–1941. 17 indexed citations
17.
Yun, Jiyeon, Sang‐Hyun Song, Jinah Park, et al.. (2012). Gene silencing of EREG mediated by DNA methylation and histone modification in human gastric cancers. Laboratory Investigation. 92(7). 1033–1044. 37 indexed citations
18.
Yun, Jiyeon, Sang‐Hyun Song, Jinah Park, et al.. (2012). Abstract 4017: Gene silencing of EREG mediated by DNA methylation and histone modification in human gastric cancers. Cancer Research. 72(8_Supplement). 4017–4017. 1 indexed citations
19.
Kim, Hyun-Seok, et al.. (2001). Immortalization of human embryonic fibroblasts by overexpression of c-myc and simian virus 40 large T antigen. Experimental & Molecular Medicine. 33(4). 293–298. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026